CIK 0001127537
- Non-accelerated filer
- Smaller reporting company
Pulmonx Corp
Sign in to watch- Ticker
- LUNG
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 650-364-0400
- Business address
- 700 CHESAPEAKE DRIVE, REDWOOD CITY, CA, 94063
- Former names
- PULMONX
- 4 Open-market sale PRESIDENT AND CEO sold 6,954 shares at $9.06 ($63,003)
- 4 Planned sale CHIEF COMMERCIAL OFFICER sold 1,184 shares at $14.20 ($16,813)
- 4 Planned sale PRESIDENT AND CEO sold 20,000 shares at $14.60 ($292,000)
- 4 Planned sale CHIEF COMMERCIAL OFFICER sold 1,184 shares at $13.13 ($15,546)
- 4 Planned sale PRESIDENT AND CEO sold 10,000 shares at $12.77 ($127,700)
- 4 Planned sale Chief Commercial Officer sold 1,184 shares at $12.75 ($15,096)
- 4 Planned sale President and CEO sold 10,000 shares at $12.42 ($124,200)
- 4 Open-market sale Chief Commercial Officer sold 2,868 shares at $10.34 ($29,655)
- 4 Open-market sale Interim CFO sold 942 shares at an average $10.34 ($9,739)
- 4 Open-market sale General Counsel sold 3,809 shares at an average $10.34 ($39,381)
- 4 Open-market sale President and CEO sold 6,676 shares at $10.34 ($69,030)
- 4 Planned sale Chief Commercial Officer sold 1,184 shares at $10.60 ($12,550)
- 4 Planned sale Chief Commercial Officer sold 1,184 shares at $8.35 ($9,886)
- 3 Insider Initial Statement of Ownership
- 4 Planned sale Chief Commercial Officer sold 1,184 shares at $10.51 ($12,444)
- 4 Open-market sale Chief Financial Officer sold 4,219 shares at an average $10.00 ($42,201)
- 4 Open-market sale Chief Commercial Officer sold 2,843 shares at $10.01 ($28,458)
- 4 Open-market sale General Counsel sold 3,772 shares at $10.01 ($37,758)
- 4 Open-market sale President and CEO sold 6,527 shares at $10.01 ($65,335)
- 4 Planned sale Chief Commercial Officer sold 1,184 shares at $10.54 ($12,479)
Page 5 of 12 · 229 filings